ClinicalTrials.gg
Drug

Catridecacog clinical trials

studies test it
12
open now
0
in phase 3
4
first study started
2003

How each study uses catridecacog is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
3 Sept 2012 · NovoThirteen · EMEA/H/C/002284 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

catridecacog
12
recombinant factor XIII
4

Studies by the year they started

12 studies that test it; most in 2003 (3)

Studies that test catridecacog, by start year
YearStudies
20033
20051
20081
20092
20103
20111
20121

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
2
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 0

Novo Nordisk A/S (12)

Studies

Open first, then newest update. How each study uses catridecacog is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Codes

What other systems call catridecacog · ClinicalTrials.gg INT017410

  • UNII (FDA) NU23Q531G1CATRIDECACOGConfirmed FDA, Wikidata
  • RxNorm 1488293Confirmed FDA, Wikidata
  • Wikidata Q16858452catridecacogConfirmed FDA, Wikidata
  • NCI Thesaurus C174766CatridecacogOne source FDA
  • DrugBank DB09310One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.